deltatrials

Non-alcoholic fatty liver disease Trials in Toronto, Canada

Conditions / Non-alcoholic fatty liver disease / Toronto, Canada

Clinical trials for Non-alcoholic fatty liver disease investigate a range of treatment strategies and patient populations.

13 total trials for this combination

Showing top 10 of 13 trials

Trials

NCT ID Title Status Phase
NCT05637866 SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic Outcomes UNKNOWN
NCT03166735 Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH COMPLETED PHASE2
NCT04048876 Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis TERMINATED PHASE2
NCT05583344 Phase 2b Study of GSK4532990 in Adults With NASH ACTIVE_NOT_RECRUITING PHASE2
NCT06465186 A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017) ACTIVE_NOT_RECRUITING PHASE2
NCT02716870 Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors UNKNOWN
NCT05877547 A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) COMPLETED PHASE2
NCT01363791 Meta-analyses of Fructose and Cardiometabolic Risk UNKNOWN
NCT02702479 Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk UNKNOWN
NCT01856465 Intestinal Microbiota and NAFLD Pre and Post Bariatric Surgery UNKNOWN

Related Pages